{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:11:23Z","timestamp":1778901083522,"version":"3.51.4"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/icu.0b013e32830b1539","type":"journal-article","created":{"date-parts":[[2008,9,4]],"date-time":"2008-09-04T07:10:26Z","timestamp":1220512226000},"page":"414-421","source":"Crossref","is-referenced-by-count":30,"title":["Targeted monoclonal antibody therapy and radioimmunotherapy for lymphoproliferative disorders of the ocular adnexa"],"prefix":"10.1097","volume":"19","author":[{"given":"Debraj","family":"Shome","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bita","family":"Esmaeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210206","article-title":"World Health Organization classification of tumours of haematopoietic and lymphoid tissues: pathology and genetics","author":"Jaffe","year":"2001"},{"key":"R2-9-20210206","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1038\/sj.onc.1207843","article-title":"The epidemiology of non-Hodgkin's lymphoma","volume":"23","author":"Fisher","year":"2004","journal-title":"Oncogene"},{"key":"R3-9-20210206","first-page":"423","article-title":"Hodgkin's and non-Hodgkin's lymphomas","author":"Hartage","year":"1994"},{"issue":"Suppl 1","key":"R4-9-20210206","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1053\/j.seminoncol.2005.01.008","article-title":"Lymphoma: diagnosis, staging, natural history, and treatment strategies","volume":"32","author":"Zinzani","year":"2005","journal-title":"Semin Oncol"},{"key":"R5-9-20210206","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1182\/blood-2006-02-005017","article-title":"Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options","volume":"108","author":"Decaudin","year":"2006","journal-title":"Blood"},{"key":"R6-9-20210206","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0360-3016(84)90051-8","article-title":"Lymphoreticular tumors of the orbit","volume":"10","author":"Fitzpatrick","year":"1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-9-20210206","first-page":"205","article-title":"Lymphoid tumors of the orbit","author":"Lambo","year":"1993"},{"key":"R8-9-20210206","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/archopht.1952.00920010336008","article-title":"Ocular involvement in lymphomatous disease","volume":"48","author":"Feinstein","year":"1952","journal-title":"Arch Ophthalmol"},{"key":"R9-9-20210206","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0161-6420(98)92107-8","article-title":"Malignant tumors of the orbit: analysis of the Florida Cancer Registry","volume":"105","author":"Margo","year":"1998","journal-title":"Ophthalmology"},{"key":"R10-9-20210206","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnci\/djj248","article-title":"Rapidly increasing incidence of ocular non-Hodgkin lymphoma","volume":"98","author":"Moslehi","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R11-9-20210206","doi-asserted-by":"crossref","first-page":"311","DOI":"10.6004\/jnccn.2006.0026","article-title":"Marginal zone lymphoma","volume":"4","author":"Shaye","year":"2006","journal-title":"J Natl Compr Canc Netw"},{"key":"R12-9-20210206","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3816\/CLM.2006.n.003","article-title":"Infectious agents in mucosa-associated lymphoid tissue-type lymphomas: pathogenic role and therapeutic perspectives","volume":"6","author":"Guidoboni","year":"2006","journal-title":"Clin Lymphoma Myeloma"},{"key":"R13-9-20210206","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1001\/archopht.125.12.1663","article-title":"Prevalence and nature of systemic involvement and stage at initial examination in patients with orbital and ocular adnexal lymphoma","volume":"125","author":"Hatef","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"R14-9-20210206","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ohc.2004.11.001","article-title":"Ocular adnexal lymphoma: classification, clinical disease, and molecular biology","volume":"18","author":"Bardenstein","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"R15-9-20210206","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0161-6420(98)98024-1","article-title":"Lymphoproliferative lesions of the ocular adnexa: analysis of 112 cases","volume":"105","author":"Coupland","year":"1998","journal-title":"Ophthalmology"},{"key":"R16-9-20210206","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0046-8177(90)90181-4","article-title":"Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987","volume":"21","author":"Knowles","year":"1990","journal-title":"Hum Pathol"},{"key":"R17-9-20210206","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1442-9071.2001.d01-18.x","article-title":"Ocular adnexal lymphoproliferative disease: a series of 73 cases","volume":"29","author":"McKelvie","year":"2001","journal-title":"Clin Exp Ophthalmol"},{"key":"R18-9-20210206","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0167-8140(00)00328-5","article-title":"Orbital lymphoma: radiotherapy outcome and complications","volume":"59","author":"Stafford","year":"2001","journal-title":"Radiother Oncol"},{"key":"R19-9-20210206","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0161-6420(01)00547-4","article-title":"Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma","volume":"108","author":"Shields","year":"2001","journal-title":"Ophthalmology"},{"key":"R20-9-20210206","first-page":"809","article-title":"Value of positron emission tomography in staging ocular adnexal lymphomas and evaluating their response to therapy","volume":"110","author":"Gayed","year":"2007","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R21-9-20210206","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0360-3016(03)00767-3","article-title":"Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes","volume":"57","author":"Fung","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R22-9-20210206","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0360-3016(98)00535-5","article-title":"Radiotherapy in the management of orbital lymphoma","volume":"44","author":"Bolek","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R23-9-20210206","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0360-3016(02)02966-8","article-title":"Curative radiotherapy for primary orbital lymphoma","volume":"54","author":"Bhatia","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R24-9-20210206","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/MOH.0b013e32818a6daf","article-title":"Defining the role of immunotherapy and radioimmunotherapy in the treatment of low-grade lymphoma","volume":"14","author":"Winter","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"R25-9-20210206","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2165\/00003495-200666060-00005","article-title":"Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia","volume":"66","author":"Cvetkovic","year":"2006","journal-title":"Drugs"},{"key":"R26-9-20210206","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/00003495-200363080-00005","article-title":"Rituximab: a review of its use in nonhodgkin's lymphoma and chronic lymphocytic leukaemia","volume":"63","author":"Plosker","year":"2003","journal-title":"Drugs"},{"key":"R27-9-20210206","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1269\/jrr.46.241","article-title":"Pretreatment with rituximab enhances radiosensitivity of non-Hodgkin's lymphoma cells","volume":"46","author":"Skvortsova","year":"2005","journal-title":"J Radiat Res (Tokyo)"},{"key":"R28-9-20210206","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","article-title":"Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group","volume":"106","author":"Hiddemann","year":"2005","journal-title":"Blood"},{"key":"R29-9-20210206","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/jnci\/djk152","article-title":"Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systemic review and meta-analysis","volume":"99","author":"Schulz","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R30-9-20210206","first-page":"1225","article-title":"Immunotherapy for low-grade non-Hodgkin secondary lymphoma of the orbit","volume":"120","author":"Esmaeli","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R31-9-20210206","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.IOP.0000115594.98470.AC","article-title":"Monoclonal antibody treatment of orbital lymphoma","volume":"20","author":"Sullivan","year":"2004","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R32-9-20210206","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.leukres.2004.05.011","article-title":"Rituximab in primary conjunctival lymphoma","volume":"29","author":"Zinzani","year":"2005","journal-title":"Leuk Res"},{"key":"R33-9-20210206","first-page":"1578","article-title":"Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa","volume":"90","author":"Ferreri","year":"2005","journal-title":"Haematologica"},{"key":"R34-9-20210206","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00277-007-0301-y","article-title":"Rituximab and chlorambucil as first line treatment for low-grade ocular adnexal lymphomas","volume":"86","author":"Rigacci","year":"2007","journal-title":"Ann Hematol"},{"key":"R35-9-20210206","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/1389201013378563","article-title":"Monoclonal antibodies: a new era in the treatment of non-Hodgkin's lymphoma","volume":"2","author":"Grillo-Lopez","year":"2001","journal-title":"Curr Pharm Biotechnol"},{"key":"R36-9-20210206","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/09553008214550451","article-title":"Radiosensitivity of human B-lymphocytic lymphomas in vitro","volume":"41","author":"Johansson","year":"1982","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"key":"R37-9-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-8140(00)00167-5","article-title":"The role of low-dose total body irradiation in treatment of non-Hodgkin's lymphoma: a new look at an old method","volume":"56","author":"Safwat","year":"2000","journal-title":"Radiother Oncol"},{"issue":"Suppl 4","key":"R38-9-20210206","first-page":"10","article-title":"Radioimmunotherapy for non-Hodgkin's lymphomas: a historical perspective","volume":"30","author":"Press","year":"2003","journal-title":"Semin Oncol"},{"key":"R39-9-20210206","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V63.6.1424.1424","article-title":"Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation","volume":"63","author":"Anderson","year":"1984","journal-title":"Blood"},{"key":"R40-9-20210206","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1080\/10428190600923140","article-title":"Current results and future applications of radioimmunotherapy management of non-Hodgkin's lymphoma","volume":"47","author":"Santos","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"R41-9-20210206","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/biot.200700043","article-title":"Yttrium 90 ibritumomab tiuxetan (Zevalin): a new bullet in the fight against malignant lymphoma?","volume":"2","author":"Chapuy","year":"2007","journal-title":"Biotechnol J"},{"key":"R42-9-20210206","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2967\/jnumed.107.043489","article-title":"Comparison of 90Y-ibritumomab tiuxetan and 131I-tositumomab in clinical practice","volume":"48","author":"Jacene","year":"2007","journal-title":"J Nucl Med"},{"key":"R43-9-20210206","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1200\/JCO.2005.07.040","article-title":"Efficacy and safety of tositumomab and iodine-131 tositumomab (Bexxar) in B-cell lymphoma, progressive after rituximab","volume":"23","author":"Horning","year":"2005","journal-title":"J Clin Oncol"},{"key":"R44-9-20210206","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1200\/JCO.2002.11.017","article-title":"Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma","volume":"20","author":"Witzig","year":"2002","journal-title":"J Clin Oncol"}],"container-title":["Current Opinion in Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICU.0b013e32830b1539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:45:03Z","timestamp":1621885503000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00055735-200809000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/icu.0b013e32830b1539","relation":{},"ISSN":["1040-8738"],"issn-type":[{"value":"1040-8738","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}